Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin Lacombe

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Chest|October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeRaphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin de Valence, Marion Delaune, Yann Nguyen, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Annals of the Rheumatic Diseases|May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEXJerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Chest|October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeRaphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin de Valence, Marion Delaune, Yann Nguyen, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Annals of the Rheumatic Diseases|May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEXJerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Pageof 6